Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × HER2 Positive Breast Cancer × Clear all

Phase

Status

Completed 4 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1131 Neoplasms 855 Carcinoma, Non-Small-Cell Lung 730 Prostatic Neoplasms 629 Colorectal Neoplasms 556 Lung Neoplasms 456 Leukemia, Myeloid, Acute 397 Pancreatic Neoplasms 364 Neoplasm Metastasis 359 Carcinoma, Hepatocellular 342 Ovarian Neoplasms 329 Multiple Myeloma 325 Stomach Neoplasms 318 Recurrence 304 Squamous Cell Carcinoma of Head and Neck 265 Melanoma 255 Uterine Cervical Neoplasms 245 Precursor Cell Lymphoblastic Leukemia-Lymphoma 225 Brain Neoplasms 225 Triple Negative Breast Neoplasms 224 Head and Neck Neoplasms 222 Glioblastoma 209 Lymphoma 208 Endometrial Neoplasms 203 Esophageal Neoplasms 197 Rectal Neoplasms 186 Sarcoma 182 Carcinoma, Renal Cell 171 Lymphoma, Non-Hodgkin 167 Colonic Neoplasms 167

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958627 2025-05-06

any

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2/3 Recruiting

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡